Search research articles
Contact Us
Filters
Showing results (91-100 of 96) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 96 results.
Scandinavian Journal of Immunology
|
May 30, 2013
IgA response to ESAT-6/CFP-10 and Rv2031 antigens varies in patients with culture-confirmed pulmonary tuberculosis, healthy Mycobacterium tuberculosis-infected and non-infected individuals in a tuberculosis endemic setting, Ethiopia
M Legesse, G Ameni, G Medhin, et al.
NIPH Annals
|
December 1, 1991
Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease
J H Fredriksen, E Rosenqvist, E Wedege, et al.
Lancet (London, England)
|
November 2, 1991
Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway
G Bjune, E A Høiby, J K Grønnesby, et al.
Scandinavian Journal of Infectious Diseases
|
January 1, 1990
Characteristics of serogroup A Neisseria meningitidis responsible for an epidemic in Ethiopia, 1988-89
R T Haimanot, D A Caugant, D Fekadu, et al.
Journal of Clinical Microbiology
|
February 1, 1994
Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories
G T Noordhoek, A H Kolk, G Bjune, et al.
Developments in Biological Standardization
|
April 29, 1998
Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine
E Rosenqvist, E A Høiby, G Bjune, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 96) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 96 results.
Scandinavian Journal of Immunology
|
May 30, 2013
IgA response to ESAT-6/CFP-10 and Rv2031 antigens varies in patients with culture-confirmed pulmonary tuberculosis, healthy Mycobacterium tuberculosis-infected and non-infected individuals in a tuberculosis endemic setting, Ethiopia
M Legesse, G Ameni, G Medhin, et al.
NIPH Annals
|
December 1, 1991
Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease
J H Fredriksen, E Rosenqvist, E Wedege, et al.
Lancet (London, England)
|
November 2, 1991
Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway
G Bjune, E A Høiby, J K Grønnesby, et al.
Scandinavian Journal of Infectious Diseases
|
January 1, 1990
Characteristics of serogroup A Neisseria meningitidis responsible for an epidemic in Ethiopia, 1988-89
R T Haimanot, D A Caugant, D Fekadu, et al.
Journal of Clinical Microbiology
|
February 1, 1994
Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories
G T Noordhoek, A H Kolk, G Bjune, et al.
Developments in Biological Standardization
|
April 29, 1998
Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine
E Rosenqvist, E A Høiby, G Bjune, et al.
Page
of 10